Abstract
Background: Common variable immunodeficiency is the primary immunodeficiency (CVID) frequently found in adults. Its prevalence is estimated from 1:25,000 to 75,000 alive newborns; there are variations by ethnic groups, it is estimated about 50-70% in Caucasian patients. Oral cavity lesions are rarely found in adult patients with CVID, there are reports about lesions on pediatric patients mostly caused by infections.
Objective: To describe the orofacial lesions (oral, maxillofacial and neck area) affecting adults with CVID.
Material and method: A transversal, prospective study was done in patients with CVID attended at Specialties Hospital, CMN SXXI, Mexico City. Patients where examined by the oral and maxillofacial surgeon and clinical findings were reported, then the descriptive analysis of the lesions was done.
Results: We evaluated 26 patients, 16 female and 10 males, average age of 38.6 years. In 18/26 patients we found oral lesions on 7 different types. The most frequent was minor salivary glands hiperplasia (19/26), petechiae (12/26) and herpetic ulcers (7/26). In head and neck, we found 4 different lesions, the most common was lymphadenopathy <2cm (4/26).
Conclusions: The immunologic alterations associated to CVID favors the development of lesions mainly of infectious and probably autoinmune origin that affects the oral cavity and head and neck area.
References
Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol 2013;174:203-211.
Blancas-Galicia L, Ramírez-Vargas NG, Espinosa-Rosales F. Inmunodeficiencia común variable. Un enfoque clínico. Revista de Investigación Clínica 2010;62:577-582.
Deane S, Selmi C, Stanley M, et al. Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol 2009;150:311-324.
Abolhassani H, et al. A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol 2013;9:561-575.
Coria-Ramírez E, Espinosa-Padilla S, Espinosa-Rosales F, Vargas-Camaño ME, Blancas-Galicia L. Panorama epidemiológico de las inmunodeficiencias primarias en México. Rev Alerg Mex 2010;57:159-163.
Notarangelo L. Primary immunodeficiencies. J Allergy Clin Immunol 2010;125:S182-S94.
www.LASID.org Estadísticas de registro periodo Ago-Oct 2013.
Szczawinska A, Gerreth K, Breborowicz A, Borysewicz L. Oral manifestations of primary immune deficiencies in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:e9-e20.
Atkinson JC, O’Connell A, Aframian D. Oral manifestations of primary immunological diseases. JADA 2000;131:345-356.
Kindt TJ, Golsbay RA, Osborne BA. Inmunología de Kuby. Capítulo 3. 6ª ed. McGraw-Hill, 2009;52-59.
Palomo GI, Ferreira A, Sepúlveda C. Fundamentos de inmunología básica y clínica. 1ª ed. Capítulo 19. Talca: Universidad de Talca, 2009;299-311.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2015 Revista Alergia México